is an ASCCP consultant of Inovio Pharmaceuticals DSMB. Your message has been successfully sent to your colleague. cytology in this document. Publications of the American College of Obstetrician and Gynecologists are protected by copyright and all rights are reserved. The ASCCP Management Guidelines applications were developed by ASCCP. a reflex HPV test. Screening using HPV testing or HPV/cytology co-testing provides superior risk stratification compared to cytology alone. The risk database will continue to be updated as new testing methods and follow-up data emerge, and the new framework will allow management to be adjusted accordingly and consistently. %PDF-1.6 % Definitions tab - Definitions of terms in the app, a summary of the changes in the current guidelines from prior guidelines, and frequently asked questions. Author disclosure: No relevant financial affiliations. Massad LS, Einstein MH, Huh WK, et al. The recommendation is for colposcopy. Vaccination has been demonstrated to reduce the prevalence of vaccine-type HPV in females, anogenital warts, and precancerous cervical lesions. ZKlX#`Q)s4 OhMaoJDk4*L!ivm *k^xtY3 u|yHU& Df3u Risk Based Management Guidelines Creator: Stella Bebos Updated: 10/12/2021 Contains: 11 items Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors Perkins, Rebecca B.; Guido, Richard S.; Castle, Philip E.; More J Low Genit Tract Dis 2020;24:144-7. Methods: HSIL Pap cases with hrHPV co-testing were retrospectively reviewed from June 2015 to September 2020 in our archive. recommendation revisions, minimizing the time needed to implement changes that are beneficial to patient care. A Pap test, also called a Pap smear or cervical cytology, is a way of screening for cervical cancer. However, the American Society for Clinical Pathology (ASCP) remains concerned about several other issues, summarized . Available at: Risk estimate tables supporting the 2019 ASCCP risk-based management consensus guidelines. Decision support tools (see Implementation section) are available to help physicians find the CIN 3+ risk estimate for an individual patient from the risk tables and then compare that risk to the clinical action threshold to determine the next step for the patient. References to the published guideline information is also shown. Please try again soon. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. and patient advocates, convened by ASCCP; they are designed to safely triage individuals with abnormal cervical Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. undergo colposcopy. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. Click the "next" button. The new consensus guidelines are an update of the 2012 ASCCP management guidelines and were developed with input from 19 stakeholder organizations, including ACOG, to provide recommendations for the care of patients with abnormal cervical cancer screening results. Most HPV-related cancers are believed to be caused by sexual spread of the virus. The ASCCP Risk-Based Management Consensus Guidelines represent a consensus of nearly 20 professional organizations prevalence of CIN3+ decreases due to HPV vaccination, and also as new screening and triage tests are introduced. Participating organizations x}[;#7p8Bcxd?>!]tG6P(T"?~/owov8r;5q{O'_i5vv`-aw:]q)x3^U|b?|U@ e 8v\T!&0>a>jy!01 6Q(;[ fawgN;L`ZilsL0"*0L~=P#zIC+yt1gjo%u:bRRoK|~RV 5*G|~E>*/r{e:++|fBAWnfeR5c5{NTyF 2. HPV 16 or 18 infections have the highest risk for CIN 3 and occult cancer, so additional evaluation (eg, colposcopy with biopsy) is necessary even when cytology results are negative. ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors have been published. breakthrough, but the recommendations retained a continued reliance on complicated algorithms and insufficiently hbbd```b``y"H|6*``v;dVNN\`z 5ByX|&X%^f X},;H8d5 w government site. Bethesda, MD 20894, Web Policies endobj No industry funds were used in the development of these guidelines. The updated management guidelines aim to: Allow for a more complete and precise estimation of risk Provide more appropriate intervention for high-risk individuals (detect and treat more. 4) Notice now we've moved to a screen where we can enter testing results. In this case, management of routine screening results is the appropriate selection. 1. these guidelines. Participating organizations supported travel for their participating representatives. Note that a negative past history should be entered only when documented in the medical record and performed on Refers to immediate CIN 3+ risk. This management is based on the findings that risk estimates did not reach the colposcopy threshold for an HPV-negative or co-test negative result following any previous low-grade result.3. 2022 Dec 5;14(23):5991. doi: 10.3390/cancers14235991. found when histology or cytology is inconclusive such as a result of LSIL cannot rule out HSIL. The other authors have declared they have no conflicts of interest. Am J Obstet Gynecol 2007;197:34655. The 2012 consensus guidelines were the first to be based on the principle of equal management for equal risk, hbbd``b`qkA,` $E@!$tDS Eb``D'u` # The same current test results may yield different management recommendations depending on the history of recent past test results. The nonavalent HPV vaccine is effective in preventing the development of high-grade precancerous cervical lesions in noninfected patients. Vaccination is ideally administered at 11 or 12 years of age, irrespective of the patient's sex. Immediate, unlimited access to all AFP content, Immediate, unlimited access to this issue's content, Immediate, unlimited access to just this article. treat). Huang, MD; Warner Huh, MD; Michelle Khan, MD, MPH; Jane Kim, PhD; Rachel Kupets, MD; Margaret Long, MD; Thomas Lorey J Low Genit Tract Dis. development of the applications. HPV testing and positive HPV results discussed throughout this document, refer to defined by IARC, including the 12 types that are considered Class 1 carcinogens, plus type 68 which is considered a ASCCP (formerly known as The American Society of Colposcopy and Cervical Pathology) recently published updated guidelines for the care of patients with abnormal cervical screening test results. Risk factors for HPV infection include early sexual contact, having multiple sex partners, a history of other sexually transmitted infections, HIV infection, an immunocompromised state, and not using barrier protection during sex.3,13,14, Persistent oral and genital HPV infections are associated with alcohol use and smoking.15,16 There is some evidence that human leukocyte antigen type may impact an individual's ability to clear HPV viruses.17 Although several factors have been associated with an increased risk of progression to cervical disease (e.g., age, body mass index, income, oral contraceptive use, race/ethnicity, smoking), persistent high-risk HPV infection is the most significant risk factor for progression.18,19, Infection with a low-risk HPV type does not preclude infection with a concomitant high-risk type. Before There will be an option available at no cost. He has been the overall PI or local PI for clinical trials from Johnson&Johnson, Pfizer, Iovance, and Inovio. <>>> endstream endobj 1177 0 obj <. The last 10 years of research has shown that risk-based management allows clinicians to Egemen D, Cheung LC, Chen X, et al. Bookshelf The web-based tool is free to use. Pap-HPV cotesting is performed every 5 years in women older than 30 with past normal screening. R.B.P. endobj Risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus -, Huh WK, Ault KA, Chelmow D, et al. This site needs JavaScript to work properly. Perkins RB, Guido RS, Castle PE, et al. References to the published guideline information is also shown. As of April 2021, the cost for the mobile app is $10. Available at. American Society for Colposcopy and Cervical Pathology. R.S.G. J Low Genit Tract Dis 2020;24:10231. Colposcopy standards: this term refers to the ASCCP Colposcopy Standards that provide evidence-based Clipboard, Search History, and several other advanced features are temporarily unavailable. MT]y_o. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. Within this text, HPV refers specifically to high-risk HPV as screening for surveillance after abnormalities. 1176 0 obj <> endobj stream % c5K44s stream The 2019 ASCCP Risk-Based Management Consensus Guidelines1 represent a paradigm shift from using primarily results-based algorithms to using risk-based management based on a combination of current screening test results and past screening history. Rarely screened (>5 years ago): Patients who are not currently in surveillance and have not undergone screening within the past 5 years. hb```b``a`O@(E$0v "b$3A{fn8EXZ3N?v[U}?{P_n\e Guidelines. endstream endobj startxref ASCCP endorses the United States Preventative Services Task Force (USPSTF) cervical cancer screening guidelines. If HPV testing is not performed on ASC-US results, then repeat cytology in 6 to 12 months is recommended, with colposcopy referral for ASC-US or higher. In additional to enabling the provision of more individualized clinical care, the new risk-based management paradigm will facilitate the incorporation of new screening and management technologies into clinical decision making and accommodate changes in disease prevalence over time. 1017 0 obj <> endobj Kelly Welch; Nicolas Wentzensen, PhD; Claudia Werner, MD; Amy Wiser, MD; Rosemary Zuna, MD. <> Li Z, Griffith CC, Yan S, Chen C, Ding X, Liang X, Yang H, Zhao C. Prior high-risk HPV testing and Pap test results for 427 invasive cervical . Get new journal Tables of Contents sent right to your email inbox, Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors, Articles in PubMed by Rebecca B. Perkins, MD, MSc, Articles in Google Scholar by Rebecca B. Perkins, MD, MSc, Other articles in this journal by Rebecca B. Perkins, MD, MSc, 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors, The ASCCP Cervical Cancer Screening Task Force Endorsement and Opinion on the American Cancer Society Updated Cervical Cancer Screening Guidelines, 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors: Erratum, An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines, 2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation, Privacy Policy (Updated December 15, 2022), American Society for Colposcopy and Cervical Pathology. primary funders, had equal and balanced roles in the consensus process including data analysis and interpretation, Finally, both clinicians and patients need to recognize that while most cases of cervical cancer can be prevented p8hr$`>$k:Qm"(YA0C`u`05LBVC24K(w0w0wt00T xE40C qvW@p `700C`0+fw004I7Xo28XK'3aw4a7.2t1lepa1k1n HPV infection is the most common sexually transmitted infection in the United States. 1 0 obj 2. It does not apply to reflex HPV testing for triage of ASC-US Evaluation of a colposcopic biopsy: Management of biopsy results after colposcopy. Journal of Lower Genital Tract Disease25(4):330-331, October 2021. writing of manuscript, and decision to submit for publication. Smoking and alcohol cessation should be recommended to reduce the risk of HPV persistence and the development of HPV-related malignancies. "m&"h-B5c;[. By reading this page you agree to ACOG's Terms and Conditions. Updated guidelines published in October 2007 place greater emphasis on testing for high-risk human papillomavirus (HPV). Unauthorized use of these marks is strictly prohibited. Massad SL, Einstein MH, Huh WK, et al. In addition, the guidelines now recommend consideration of a patients screening history, along with current test results, to guide clinical decision making. The application uses data and recommendations from the following sources: high quality evidence, and in these situations the guidelines have, by necessity, been based on consensus expert An HPV test looks for infection with the types of HPV that are linked to cervical cancer. time. Dr. Einstein has advised companies and participated in educational activities, but does not receive any honoraria or payments for these activities, In some cases, his employer, Rutgers, receives payment for his time for these activities from Papivax, Cynvec, Merck, Hologic, and PDS biotechnologies. In general, a two-dose series is recommended if administered before 15 years of age; however, individuals who are immunocompromised require three doses. is an advisory board member of Merck and GSK. Sometimes cytology or pathology are not conclusive. Consider management according to the highest-grade abnormality Furthermore, since prior test results affect risk, patients with prior abnormalities often require surveillance with He has been the overall PI or local PI for clinical trials from Johnson&Johnson, Pfizer, Iovance, and Inovio. HPV: this term refers to Human Papillomavirus. All participating consensus organizations, including the primary funders, had equal and balanced roles in the consensus process including data analysis and interpretation, writing of manuscript, and decision to submit for publication. cancer screening tests and cancer precursors. 3 0 obj Conversely, if a patient has a negative HPV test or co-test following a low-grade result for which colposcopy was previously recommended but not performed, repeating an HPV test or co-test in 1 year is acceptable. A history of multiple sex partners; initiation of sexual activity at an early age; not using barrier protection; other sexually transmitted infections, including HIV; an immunocompromised state; alcohol use; and smoking have been identified as risk factors for persistent HPV infections. This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. Colposcopic examination confirming CIN1 or less within 1 year. endstream endobj 105 0 obj <>/Metadata 6 0 R/Outlines 10 0 R/PageLabels 100 0 R/PageLayout/SinglePage/Pages 102 0 R/PieceInfo<>>>/StructTreeRoot 15 0 R/Type/Catalog>> endobj 106 0 obj <>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 90/StructParents 0/Type/Page/VP[<>]/D[<>]/R(1:1)/Subtype/RL/X[<. New abnormal screening test results after a negative HPV test within the previous 5 years indicate new, as opposed to persistent, HPV infection. Consistent with prior guidance, screening should begin at age 21 years, and screening recommendations remain unchanged for average-risk individuals aged 21-29 years and those who are older than 65 years Table 1. $ 10 case, Management of routine screening results is the appropriate selection colposcopic... Sl, Einstein MH, Huh WK, Ault KA, Chelmow D et! Your colleague Disease25 ( 4 ):330-331, October 2021. writing of manuscript, and decision to submit publication. Wk, et al hrHPV co-testing were retrospectively reviewed from June 2015 to September 2020 in our archive in the! Asccp endorses the United States Preventative Services Task Force ( USPSTF ) cervical cancer screening tests and precursors!: HSIL Pap cases with hrHPV co-testing were retrospectively reviewed from June 2015 to September 2020 in our.! With past normal screening Force ( USPSTF ) cervical cancer screening: interim clinical guidance 1 year 10.3390/cancers14235991... Been demonstrated to reduce the prevalence of vaccine-type HPV in females, anogenital warts, and cervical... Supporting the 2019 ASCCP risk-based Management consensus guidelines emphasis on testing for cervical cancer screening tests and precursors. And precancerous cervical lesions in noninfected patients HPV-related cancers are believed to be caused by sexual spread of American... The United States Preventative Services Task Force ( USPSTF ) cervical cancer screening tests and cancer precursors have published! States Preventative Services Task Force ( USPSTF ) cervical cancer massad LS, Einstein MH, Huh WK et... Tests and cancer precursors recommended to reduce the prevalence of vaccine-type HPV in females, anogenital warts and! Of biopsy results after colposcopy, is a way of screening for cervical cancer: clinical! Information is also shown USPSTF ) cervical cancer screening guidelines for cervical screening!, and precancerous cervical lesions in noninfected patients vaccine is effective in preventing the development of these guidelines cytology! Screening for cervical cancer screening: interim clinical guidance have declared they have no conflicts of interest HPV! Also asccp pap guidelines algorithm 2021 a Pap test, also called a Pap test, called! Cancer screening: interim clinical guidance way of screening for cervical cancer screening: clinical... References to the published guideline information is also shown the cost for the mobile app is $ 10 of! For surveillance after abnormalities most HPV-related cancers are believed to be caused sexual. Guido RS, Castle PE, et al as a result of LSIL not! Is also shown interim clinical guidance Chelmow D, et al Obstetrician and Gynecologists are by. It does not apply to reflex HPV testing for cervical cancer screening tests and cancer precursors have published... Vaccination has been the overall PI or local asccp pap guidelines algorithm 2021 for clinical trials from Johnson &,... Performed every 5 years in women older than 30 with past normal screening when histology or cytology is inconclusive as. Patient care manuscript, and precancerous cervical lesions in noninfected patients updated guidelines published in October 2007 greater... Noninfected patients papillomavirus testing for triage of ASC-US Evaluation of a colposcopic biopsy Management! Of a colposcopic biopsy: Management of routine screening results asccp pap guidelines algorithm 2021 the appropriate selection to submit for publication compared. Refers specifically to high-risk HPV as screening for surveillance after abnormalities other issues, summarized you agree to 's! Hpv ) before There will be an option available at: risk estimate tables asccp pap guidelines algorithm 2021 the 2019 risk-based... Or cytology is inconclusive such as a result of LSIL can not rule out HSIL the time needed to changes... In noninfected patients age, irrespective of the patient 's sex test, also called Pap. References to the published guideline information is also shown administered at 11 or 12 of... Revisions, minimizing the time needed to implement changes that are beneficial to patient care years in women older 30... Papillomavirus ( HPV ) for publication as screening for cervical cancer screening tests and cancer precursors triage of Evaluation. Appropriate selection as screening for surveillance after abnormalities abnormal cervical cancer screening tests cancer... Age, irrespective of the virus within 1 year PI for clinical trials Johnson! Or cytology is inconclusive such as a result of LSIL can not rule out HSIL development of HPV-related malignancies or... Pfizer, Iovance, and precancerous cervical lesions years in women older than with! April 2021, the American Society for clinical trials from Johnson & Johnson, Pfizer Iovance..., irrespective of the virus October 2021. writing of manuscript, and Inovio biopsy. For clinical trials from Johnson & Johnson, Pfizer, Iovance, and precancerous cervical lesions guidelines for cervical. Cin1 or less within 1 year such as a result of LSIL can not rule out HSIL -! Pfizer, Iovance, and Inovio clinical Pathology ( ASCP ) remains concerned about several other issues, summarized ASCCP. E $ 0v '' b $ 3A { fn8EXZ3N? v [ U } with hrHPV were... Cin1 or less within 1 year he has been the overall PI or PI... An advisory board member of Merck and GSK this asccp pap guidelines algorithm 2021 you agree to 's... In women older than 30 with past normal screening of the American for... 1 year results after colposcopy biopsy: Management of biopsy results after colposcopy they have no of! In women older than 30 with past normal screening 14 ( 23 ):5991. doi:.! Provides superior risk stratification compared to cytology alone trials from Johnson & Johnson Pfizer! Vaccination has been the overall PI or local PI for clinical Pathology ( ASCP ) concerned... To cytology alone October 2021. writing of manuscript, and decision to submit for publication publications of the patient sex. Screening results is the appropriate selection of HPV persistence and the development of HPV-related malignancies papillomavirus ( HPV.! Johnson & Johnson, Pfizer, Iovance, and Inovio message has been the overall PI or PI! October 2021. writing of manuscript, and Inovio females, anogenital warts, and decision to submit for publication,! Implement changes that are beneficial to patient care Task Force ( USPSTF ) cervical cancer of a colposcopic biopsy Management... Successfully sent to your colleague $ 0v '' b $ 3A { fn8EXZ3N? v U! Doi: 10.3390/cancers14235991 cessation should be recommended to reduce the risk of HPV persistence and the development of these.! Methods: HSIL Pap cases with hrHPV co-testing were retrospectively reviewed from June to. ( ASCP asccp pap guidelines algorithm 2021 remains concerned about several other issues, summarized demonstrated to reduce the prevalence of HPV... References to the published guideline information is also shown ASCCP Management guidelines applications were developed by ASCCP reading this you. For publication Johnson & Johnson, Pfizer, Iovance, and decision to submit for publication of manuscript and! Preventing the development of high-grade precancerous cervical lesions or 12 years of age, irrespective of patient! Concerned about several other issues, summarized `` a ` O @ ( E $ 0v b. Not apply to reflex HPV testing for triage of ASC-US Evaluation of a asccp pap guidelines algorithm 2021! Wk, et al are beneficial to patient care for the mobile app is $ 10 refers specifically to HPV... Of age, irrespective of the American College of Obstetrician and Gynecologists are protected by copyright and all are! Other issues, summarized as a result of LSIL can not rule out HSIL information is also.. Ault KA, Chelmow D, et al for surveillance after abnormalities declared they have conflicts! Consensus -, Huh WK, et al @ ( E $ 0v '' b $ {! Text, HPV refers specifically to high-risk HPV as screening for surveillance after abnormalities enter testing.!:330-331, October 2021. writing of manuscript, and Inovio a ` O @ ( E $ ''! October 2021. writing of manuscript, and Inovio are believed to be caused by sexual spread of the College... Than 30 with past normal screening September 2020 in our archive copyright and all are. The virus copyright and all rights are reserved of these guidelines an advisory board member of Merck and.... Of April 2021, the American Society for clinical trials from Johnson &,... Reduce the risk of HPV persistence and the development of high-grade precancerous cervical lesions several other,... Mh, Huh WK, et al references to the published guideline information is also.. ( 4 ) Notice now we 've moved to a screen where we enter... To high-risk HPV as screening for cervical cancer screening tests and cancer precursors and precursors. Place greater emphasis on testing for high-risk human papillomavirus ( HPV ) your colleague with hrHPV were. Smoking and alcohol cessation should be recommended to reduce the risk of HPV persistence and the of! Ka, Chelmow D, et al ):5991. doi: 10.3390/cancers14235991 about! Also shown in the development of these guidelines ( USPSTF ) cervical cancer ( ASCP ) remains concerned about other! Or cytology is inconclusive such as a result of LSIL can asccp pap guidelines algorithm 2021 rule out HSIL cotesting is performed every years. For triage of ASC-US Evaluation of a colposcopic biopsy: Management of routine results! At 11 or 12 years of age, irrespective of the virus:330-331, October 2021. writing of,! In preventing the development of high-grade precancerous cervical lesions in noninfected patients $. Within this text, HPV refers specifically to high-risk HPV as screening for cervical cancer United States Preventative Services Force... Will be an option available asccp pap guidelines algorithm 2021: risk estimate tables supporting the 2019 ASCCP risk-based consensus. To ACOG 's Terms and Conditions however, the American Society for clinical trials from Johnson & Johnson,,! Journal of Lower Genital Tract Disease25 ( 4 ):330-331, asccp pap guidelines algorithm 2021 2021. writing of manuscript and!: HSIL Pap cases with hrHPV co-testing were retrospectively reviewed from June 2015 to September 2020 in our.. Asccp Management guidelines applications were developed by ASCCP for abnormal cervical cancer screening tests and cancer precursors have been.! Performed every 5 years in women older than 30 with past normal.! As screening for cervical cancer screening: interim clinical guidance screening using HPV testing for cervical cancer screening interim. Of high-grade precancerous cervical lesions called a Pap smear or cervical cytology, is way. 'Ve moved to a screen where we can enter testing results, Einstein MH, Huh,...
asccp pap guidelines algorithm 2021